2022 Antacids Market Size, Share, Price, Trend And Forecast To 2031

Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!
https://www.thebusinessresearchcompany.com/opportunities-and-strategies-reports

The global antacids market report by the business research company Poor lifestyle choices resulting in a higher prevalence of acidity are an important to be a major growth driver for the antacids market. Poor lifestyle choices involve deskbound jobs, poor quality of sleep, and irregular dietary habits, which result in an increase in the acidity level of the stomach and lead to gastroesophageal reflux disease. According to the American College of Gastroenterology, around 60 million Americans suffer from gastroesophageal reflux disease. This drives the demand for antacids

The global antacids market grew from $8.58 billion in 2021 to $9.17 billion in 2022 at a compound annual growth rate (CAGR) of 6.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The antacids market is expected to grow to $10.24 billion in 2026 at a CAGR of 2.8%.

Purchase The Antacids Market Report Here:
https://www.thebusinessresearchcompany.com/report/antacids-global-market-report

North America was the largest region in the antacids market in 2021. Middle East is expected to be the fastest growing region. The regions covered in the antacids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Major players in the antacids market are GlaxoSmithKline plc, Pfizer Inc., Bayer AG, Dr. Reddy's Laboratories Ltd and AstraZeneca PLC., Boehringer Ingelheim GmbH, Sun Pharmaceuticals Industries Ltd, Takeda Pharmaceutical Company Limited, Abbott Laboratories and WellSpring Pharm

The global antacids market is segmented -
1) Drug Class: Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents
2) Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Others
3) By Formulation Type: Tablet, Liquid, Powder, Others

Request A Sample Of The Antacids Market Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2415&type=smp

The Antacids market Report Contents Include
1. Executive Summary
2. Antacids Market Characteristics
3. Antacids Market Trends And Strategies
4. Antacids Market - Macro Economic Scenario
5. Antacids Market Size And Growth
......
27. Antacids Market Competitive Landscape And Company Profiles
28. Antacids Pipeline Analysis
29. Key Mergers And Acquisitions In The Antacids Market
30. Antacids Market Future Outlook and Potential Analysis
31. Appendix

This report covers the trends and market dynamics of the antacids market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
TBRC Blog: http://blog.tbrc.info/
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Healthcare Blog: https://healthcareresearchreports.com/

About Us:
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. It has published over 3000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

This release was published on openPR.